Latest News
Deepak Cyril D'Souza, MD, Vikram Sodhi ’92 Professor of Psychiatry, is co-author of the opinion piece "Funding, High-Quality Science, are Essential to the Future of Psychedelic Therapies" in Lucid News.
- August 15, 2024
Yale scientists, led by first author Priya Gupta, PhD, postdoctoral associate, and senior author Daniel F. Levey, PhD, assistant professor of psychiatry, investigated the complex underlying genetic architecture of the "big five" personality traits in a cohort of 682,688 people, the largest study of its kind. The results were published in Nature Human Behavior.
- August 15, 2024
Hang Zhou, PhD, assistant professor of psychiatry, and Joel Gelernter, MD, Foundations Fund Professor of Psychiatry and professor of genetics and of neuroscience, are co-authors of a paper in The Journal of Clinical Investigation that reviews progress of human genetic and epigenetic study of alcohol use disorder and summarizes key future directions including applications of whole-genome sequencing, multi-omics and data science approaches.
- August 15, 2024Source: Journal of Addiction Medicine
In a review in the Journal of Addiction Medicine, Yale authors conclude current evidence supports medications for opioid use disorder safety and effectiveness in reducing nonmedical opioid use. Co-first authors are Oluwole Jegede, MD, MPH, left, and Joao P. De Aquino, MD, center. Senior author is Srinivas Muvvala, MD, MPH, right.
- August 14, 2024
Chronic limb-threatening ischemia (CLTI) is the most advanced form of peripheral artery disease (PAD). A new paper from Yale researchers investigates the factors that impact mortality in patients with CLTI. In the following interview, they highlight the findings of their new paper and discuss why the field of medicine should adjust its approach to caring for patients with CLTI.
- August 14, 2024Source: Scientific American
Opioid use disorder treatment needs to take into account evolving cannabis policies, to help give people the best chances of recovery, writes Joao P. De Aquino, MD, assistant professor of psychiatry, in Scientific American.
- August 14, 2024Source: Psychology Today
Lisa Fucito, PhD, associate professor of psychiatry and director of the Yale Tobacco Treatment Service, spoke to Psychology Today about her study of the drug varenicline, used for cessation of e-cigarette use.
- August 13, 2024
John Cahill, MD, PhD, associate professor of psychiatry, has been selected to be director of the Yale Psychiatry Residency Program.
- August 13, 2024
Henrique Oliva, MD, PhD, a postdoctoral associate in the Yale Department of Psychiatry, has been selected to receive the John Renner Travel Award from the American Academy of Addiction Psychiatry (AAAP).
- August 12, 2024
A new study led by National Center for PTSD and Yale researchers analyzed data from a large, population-based sample of U.S. military veterans to identify factors — both positive and negative — associated with mental, physical, psychosocial, and cognitive functioning.